96 related articles for article (PubMed ID: 1026339)
1. Synchronization with phase-specific agents in leukemia and correlation with clinical response to chemotherapy.
Vogler WR; Kremer WB; Knospe WH; Omura GA; Tornyos K
Cancer Treat Rep; 1976 Dec; 60(12):1845-59. PubMed ID: 1026339
[TBL] [Abstract][Full Text] [Related]
2. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
Kremer WB; Vogler WR; Chan YK
Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
Burke PJ; Karp JE; Vaughan WP
J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
[TBL] [Abstract][Full Text] [Related]
4. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
Moran RE; Straus MJ
Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
6. Synchronization and recruitment in acute leukemia.
Lampkin BC; Nagao T; Mauer AM
J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
[TBL] [Abstract][Full Text] [Related]
7. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
Killmann SA
Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
[No Abstract] [Full Text] [Related]
8. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
9. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
Blumenreich MS; Chou TC; Andreeff M; Vale K; Clarkson BD; Young CW
Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380
[TBL] [Abstract][Full Text] [Related]
10. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
[TBL] [Abstract][Full Text] [Related]
11. A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia.
Rowinsky EK; Kaufmann SH; Baker SD; Miller CB; Sartorius SE; Bowling MK; Chen TL; Donehower RC; Gore SD
Clin Cancer Res; 1996 Dec; 2(12):1921-30. PubMed ID: 9816150
[TBL] [Abstract][Full Text] [Related]
12. [Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia].
Wakita A; Murase T; Uchida T; Fujiwara Y; Tanaka M; Ohkita T
Gan To Kagaku Ryoho; 1992 May; 19(5):653-7. PubMed ID: 1580638
[TBL] [Abstract][Full Text] [Related]
13. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
[TBL] [Abstract][Full Text] [Related]
14. Rapid control of chronic granulocytic leukaemia.
Onwukeme KE; Lot TY
Afr J Med Med Sci; 1993 Jun; 22(2):51-6. PubMed ID: 7839898
[TBL] [Abstract][Full Text] [Related]
15. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
Cassileth PA; Kahn SB; Silber R; Weiler C
Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the growth of leukemic cells in vitro to the outcome of therapy for acute nonlymphocytic leukemia.
Preisler HD; Azarnia N; Marinello M
Cancer Res; 1984 Apr; 44(4):1712-7. PubMed ID: 6704977
[TBL] [Abstract][Full Text] [Related]
17. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot G; Weber G
Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
O'Brien S; Benvenuto JA; Estey E; Beran M; Felder TB; Keating M
Cancer Res; 1991 Feb; 51(3):935-8. PubMed ID: 1988134
[TBL] [Abstract][Full Text] [Related]
19. Effects of rGM-CSF on leukemia cell proliferation and on the incorporation of cytosine arabinoside into DNA.
Gao XZ; Yin MY; Wang ZQ; Raza A; Preisler HD
Cell Biochem Funct; 1991 Jul; 9(3):155-61. PubMed ID: 1752023
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics.
Alberts DS; Durie BG; Salmon SE
Cancer Treat Rep; 1977; 61(3):381-8. PubMed ID: 872138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
